Association between chronic immune-mediated inflammatory diseases and cardiovascular risk

Objective: To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders...

Full description

Bibliographic Details
Authors: Baena Díez, José Miguel; García Gil, Maria; Comas Cufí, Marc; Ramos, Rafel; Prieto Alhambra, Daniel; Salvador González, Betlem; Elosua, Roberto; Degano, Irene R.; Peñafiel, Judith; Grau, Maria
Format: Article
Status:Accepted version
Publication date:2018
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/178169
Online Access:https://hdl.handle.net/2445/178169
Access Level:Open access
Keyword:Malalties cardiovasculars
Inflamació
Cardiovascular diseases
Inflammation
_version_ 1878732736850558976
author Baena Díez, José Miguel
author2 García Gil, Maria
Comas Cufí, Marc
Ramos, Rafel
Prieto Alhambra, Daniel
Salvador González, Betlem
Elosua, Roberto
Degano, Irene R.
Peñafiel, Judith
Grau, Maria
author2_role author
author
author
author
author
author
author
author
author
author_browse Baena Díez, José Miguel
Comas Cufí, Marc
Degano, Irene R.
Elosua, Roberto
García Gil, Maria
Grau, Maria
Peñafiel, Judith
Prieto Alhambra, Daniel
Ramos, Rafel
Salvador González, Betlem
author_facet Baena Díez, José Miguel
García Gil, Maria
Comas Cufí, Marc
Ramos, Rafel
Prieto Alhambra, Daniel
Salvador González, Betlem
Elosua, Roberto
Degano, Irene R.
Peñafiel, Judith
Grau, Maria
author_role author
collection Recercat. Dipósit de la Recerca de Catalunya
description Objective: To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies) and the 6-year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality; and to estimate the population attributable fractions for all four end-points for each chronic immune-mediated inflammatory disease. Methods: Cohort study of individuals aged 35-85 years, with no history of cardiovascular disease from Catalonia (Spain). The coded diagnoses of chronic immune-mediated diseases and cardiovascular diseases were ascertained and registered using validated codes, and date of death was obtained from administrative data. Cox regression models for each outcome according to exposure were fitted to estimate HRs in two models 1 : after adjustment for sex, age, cardiovascular risk factors and 2 further adjusted for drug use. Population attributable fractions were estimated for each exposure. Results: Data were collected from 991 546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: HR=1.31 (95% CI 1.15 to 1.49)), rheumatoid arthritis (HR=1.43 (95% CI 1.26 to 1.62) and HR=1.31 (95% CI 1.15 to 1.49)) and inflammatory bowel diseases (HR=1.18 (95% CI 1.06 to 1.32) and HR=1.12 (95% CI 1.01 to 1.25)). The effect of anti-inflammatory treatment was significant in all instances (HR=1.50 (95% CI 1.24 to 1.81); HR=1.47 (95% CI 1.23 to 1.75); HR=1.43 (95% CI 1.19 to 1.73), respectively). The population attributable fractions for all three disorders were 13.4%, 15.7% and 10.7%, respectively. Conclusion: Systemic connective tissue disorders and rheumatoid arthritis conferred the highest cardiovascular risk and population impact, followed by inflammatory bowel diseases.
eu_rights_str_mv openAccess
format article
id ES_48c84416a6d7b8f5c833e44add8d7607
institution Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:recercat.cat:2445/178169
publishDate 2018
publishDateSort 2018
publisher BMJ Publishing Group & British Cardiovascular Society
publisherStr BMJ Publishing Group & British Cardiovascular Society
reponame_str Recercat. Dipósit de la Recerca de Catalunya
spelling Association between chronic immune-mediated inflammatory diseases and cardiovascular risk Baena Díez, José Miguel García Gil, Maria Comas Cufí, Marc Ramos, Rafel Prieto Alhambra, Daniel Salvador González, Betlem Elosua, Roberto Degano, Irene R. Peñafiel, Judith Grau, Maria Malalties cardiovasculars Inflamació Cardiovascular diseases Inflammation Objective: To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies) and the 6-year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality; and to estimate the population attributable fractions for all four end-points for each chronic immune-mediated inflammatory disease. Methods: Cohort study of individuals aged 35-85 years, with no history of cardiovascular disease from Catalonia (Spain). The coded diagnoses of chronic immune-mediated diseases and cardiovascular diseases were ascertained and registered using validated codes, and date of death was obtained from administrative data. Cox regression models for each outcome according to exposure were fitted to estimate HRs in two models 1 : after adjustment for sex, age, cardiovascular risk factors and 2 further adjusted for drug use. Population attributable fractions were estimated for each exposure. Results: Data were collected from 991 546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: HR=1.31 (95% CI 1.15 to 1.49)), rheumatoid arthritis (HR=1.43 (95% CI 1.26 to 1.62) and HR=1.31 (95% CI 1.15 to 1.49)) and inflammatory bowel diseases (HR=1.18 (95% CI 1.06 to 1.32) and HR=1.12 (95% CI 1.01 to 1.25)). The effect of anti-inflammatory treatment was significant in all instances (HR=1.50 (95% CI 1.24 to 1.81); HR=1.47 (95% CI 1.23 to 1.75); HR=1.43 (95% CI 1.19 to 1.73), respectively). The population attributable fractions for all three disorders were 13.4%, 15.7% and 10.7%, respectively. Conclusion: Systemic connective tissue disorders and rheumatoid arthritis conferred the highest cardiovascular risk and population impact, followed by inflammatory bowel diseases. BMJ Publishing Group & British Cardiovascular Society https://hdl.handle.net/2445/178169
spellingShingle Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
Baena Díez, José Miguel
Malalties cardiovasculars
Inflamació
Cardiovascular diseases
Inflammation
status_str acceptedVersion
title Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
title_full Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
title_fullStr Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
title_full_unstemmed Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
title_short Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
title_sort Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
topic Malalties cardiovasculars
Inflamació
Cardiovascular diseases
Inflammation
topic_facet Malalties cardiovasculars
Inflamació
Cardiovascular diseases
Inflammation
url https://hdl.handle.net/2445/178169